Compare AU

Compare QAU vs. DRUG

Compare shares and ETFs on the ASX that you can trade on Pearler.

BetaShares Gold Bullion ETF - Currency Hedged

ASX

Buy

Buy

Overview
Performance

Overview

When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the BetaShares Gold Bullion ETF - Currency Hedged (QAU) and the BetaShares Global Healthcare ETF - Currency Hedged (DRUG). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.

Community Stats

QAU

DRUG

Popularity

Low

Low

Pearlers invested

53

63

Median incremental investment

$1,004.86

$990.50

Median investment frequency

Monthly

Monthly

Median total investment

$1,964.70

$1,910.37

Average age group

> 35

26 - 35


Key Summary

QAU

DRUG

Strategy

QAU.AX was created on 2011-05-03 by BetaShares. The fund's investment portfolio concentrates primarily on gold commodities. The investment objective of the Fund is to provide an investment return, before fees and expenses, that closely tracks the performance of the price of gold bullion, with a currency hedge against movements in the AUD/USD exchange rate.

DRUG.AX was created on 2016-08-04 by BetaShares. The fund's investment portfolio concentrates primarily on health care equity. DRUG.AX aims to track the performance of an index (before fees and expenses) that comprises the largest global healthcare companies (ex-Australia), hedged into Australian dollars.

Top 3 holdings

LONDON GOLD MARKET FIXING LTD GOLD BULLION GOLD BULLION (98.21 %)

AUD - AUSTRALIA DOLLAR (94.44 %)

USD - UNITED STATES DOLLAR (-92.65 %)

CHF - SWISS FRANC (0 %)

AUD - AUSTRALIA DOLLAR (0 %)

DKK - DANISH KRONE (0 %)

Top 3 industries

Other (66.71 %)

Communication Services (33.29 %)

Other (75.53 %)

Communication Services (33.53 %)

Health Care (24.47 %)

Top 3 countries

United States (71.71 %)

Switzerland (8.14 %)

Denmark (6.30 %)

Management fee

0.59 %

0.57 %


Key Summary

QAU

DRUG

Issuer

BetaShares

BetaShares

Tracking index

LBMA Gold Price AM ($/ozt)

Nasdaq Global ex-Australia Healthcare Hedged AUD Index - AUD

Asset class

ETF

ETF

Management fee

0.59 %

0.57 %

Price

$21.83

$8.27

Size

$692.105 million

$182.401 million

10Y return

74.50 %

N/A

Annual distribution yield (5Y)

1.57 %

1.90 %

Market

ASX

ASX

First listed date

04/05/2011

08/08/2016

Purchase fee

$6.50

$6.50


Community Stats

QAU

DRUG

Popularity

Low

Low

Pearlers invested

53

63

Median incremental investment

$1,004.86

$990.50

Median investment frequency

Monthly

Monthly

Median total investment

$1,964.70

$1,910.37

Average age group

> 35

26 - 35


Pros and Cons

QAU

DRUG

Pros

  • Higher price growth

  • Higher exposure to US market

  • Lower management fee

  • Higher distribution yield

Cons

  • Lower exposure to US market

  • Higher management fee

  • Lower distribution yield

  • Lower price growth

QAU

DRUG

Lower exposure to US market

Higher exposure to US market

Higher management fee

Lower management fee

Higher price growth

Lower price growth

Lower distribution yield

Higher distribution yield

Home